Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.


Journal article


Clin Cancer Res

Publication Date





1917 - 1921


Adult, Aged, Angiogenesis Inducing Agents, Carcinoma, Non-Small-Cell Lung, Endothelial Growth Factors, Female, Fibroblast Growth Factor 2, Humans, Immunohistochemistry, Lung Neoplasms, Lymphokines, Male, Middle Aged, Mucin-1, Neoplasm Metastasis, Neoplasm Staging, Neovascularization, Pathologic, Receptor Protein-Tyrosine Kinases, Receptor, Fibroblast Growth Factor, Type 2, Receptors, Fibroblast Growth Factor, Receptors, Growth Factor, Receptors, Vascular Endothelial Growth Factor, Thymidine Phosphorylase, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors